A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants

NCT01515358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: LY3000328

Sponsor

Eli Lilly and Company